Per Tornvall Selected Research

Non-ST Elevated Myocardial Infarction

11/2017	Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.
6/2016	Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Per Tornvall Research Topics

Disease

24	Myocardial Infarction 09/2023 - 04/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 04/2003
17	Inflammation (Inflammations) 09/2023 - 05/2003
11	ST Elevation Myocardial Infarction 11/2021 - 09/2005
9	MINOCA 12/2023 - 01/2018
8	Takotsubo Cardiomyopathy 11/2021 - 01/2013
8	Cardiovascular Diseases (Cardiovascular Disease) 03/2018 - 08/2003
6	Atrial Fibrillation 11/2023 - 04/2009
6	Atherosclerosis 01/2023 - 04/2003
6	Coronary Disease (Coronary Heart Disease) 01/2018 - 11/2004
5	Infarction (Infarctions) 11/2021 - 03/2013
4	Acute Coronary Syndrome 03/2024 - 02/2007
4	Infections 09/2023 - 05/2005
4	Thrombosis (Thrombus) 01/2018 - 07/2012
4	Stable Angina 01/2014 - 05/2005
3	Heart Failure 05/2020 - 06/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 12/2007
3	Neoplasms (Cancer) 09/2013 - 11/2004
3	Unstable Angina 12/2007 - 11/2005
3	Coronary Stenosis (Coronary Artery Stenosis) 12/2007 - 06/2002
2	Heart Arrest (Cardiac Arrest) 11/2023 - 02/2010
2	Hemorrhage 01/2018 - 11/2014
2	Non-ST Elevated Myocardial Infarction 11/2017 - 06/2016
2	Reperfusion Injury 10/2013 - 09/2005
2	Ischemia 10/2013 - 12/2007
2	Malaria 10/2011 - 01/2010
2	Hypertension (High Blood Pressure) 03/2011 - 02/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2004 - 12/2003
1	Thrombophilia 01/2022
1	Pheochromocytoma 11/2021
1	Severe Acute Respiratory Syndrome 11/2021
1	Iron Deficiencies 05/2020
1	Cytokine Release Syndrome 01/2020
1	COVID-19 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Pathologic Constriction (Stenosis) 01/2018
1	Heart Diseases (Heart Disease) 01/2018

Drug/Important Bio-Agent (IBA)

14	C-Reactive ProteinIBA 01/2023 - 05/2003
12	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2003
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2003
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 09/2012
4	CytokinesIBA 01/2020 - 10/2011
4	Troponin T (Troponin T1)IBA 01/2018 - 11/2005
4	trans-sodium crocetinate (crocetin)IBA 04/2016 - 01/2014
3	Immunoglobulin G (IgG)IBA 01/2022 - 03/2015
3	Atorvastatin (Lipitor)FDA Link 09/2013 - 04/2009
3	Plasminogen Activator Inhibitor 1IBA 09/2012 - 11/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2005
2	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 11/2023 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2019
2	CatecholaminesIBA 11/2021 - 01/2018
2	AntibodiesIBA 11/2021 - 02/2011
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 11/2016
2	LipidsIBA 01/2020 - 01/2005
2	TicagrelorIBA 01/2019 - 11/2017
2	Dobutamine FDA LinkGeneric 07/2015 - 12/2014
2	AutoantibodiesIBA 03/2015 - 04/2003
2	InterleukinsIBA 10/2012 - 10/2006
2	NF-kappa B (NF-kB)IBA 08/2010 - 03/2010
2	Fibrinogen (Factor I)FDA Link 07/2008 - 03/2005
2	Factor VII (Proconvertin)IBA 07/2007 - 08/2005
1	Protein C InhibitorIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Protein CIBA 01/2022
1	Antiphospholipid AntibodiesIBA 01/2022
1	Cardiolipins (Cardiolipin)IBA 01/2022
1	MetanephrineIBA 11/2021
1	NormetanephrineIBA 11/2021
1	ArginaseIBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	IronIBA 05/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	EicosanoidsIBA 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	Agouti-Related ProteinIBA 01/2019
1	CreatinineIBA 01/2019
1	methylnaltrexone FDA Link 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	P-SelectinIBA 01/2019
1	ChemokinesIBA 01/2019
1	LigandsIBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	ReninIBA 01/2019
1	LDL CholesterolIBA 01/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2018

Therapy/Procedure

10	Percutaneous Coronary Intervention 11/2017 - 06/2002
8	Therapeutics 01/2021 - 01/2005
5	Stents 01/2018 - 05/2005
3	Electric Countershock (Cardioversion) 01/2021 - 04/2009
2	Secondary Prevention 01/2021 - 01/2018
2	Catheters 01/2014 - 05/2011
2	Radiotherapy 09/2013 - 03/2010